Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by Microvessel density after immunohistochemical staining for CD34

Ultrastructural Pathology

Volumn 36, Issue 5, 2012, Pages 336-342

  Ajili, Faouzia ^a,b   Kacem, Monia ^a   Tounsi, Haifa ^a   Darouiche, Amine ^c   Enayfer, Emna ^a   Chebi, Mouhamed ^c   Manai, Mouhamed ^b   Boubaker, Samir ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^c CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Angiogenesis; BCG immunotherapy; Bladder cancer; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CD34 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CHI SQUARE DISTRIBUTION; DISEASE FREE SURVIVAL; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KAPLAN MEIER METHOD; MALE; MICROVASCULATURE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BCG VACCINE; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MICROVESSELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84866906171     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2012.672847     Document Type: Article

References (29)

1. Saint F, Salomon L, Quintela R. Do prognostic parameters of remission versus relapse after bacillus Calmette-Guerin (BCG) immunotherapy exist? Analysis of a quarter century of literature. Eur Urol. 2003;43:351-361. (Pubitemid 36427453)
2. Kohler HH, Barth PJ, Siebel A, et al. Quantitative assessment of vascular surface density in renal cell carcinomas. Br J Urol. 1996;77:650-654. (Pubitemid 27402269)
3. Yorükoǧlu K, Saǧol Ö, Özkara E, et al. Comparison of microvascularization in diagnostic needle biopsies and radical prostatectomies in prostate carcinoma. Eur Urol. 1999;35:109-112. (Pubitemid 29080242)
4. Stein JP, Grossfeld GD, Ginsberg D, et al. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol. 1998;160:645-659. (Pubitemid 29479481)
5. Bochner BH, Cote RJ, Weidner N, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst. 1995;87: 1603-1612.
6. Philip EA, Stephenson TJ, Reed MWR. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br J Urol.1996;77:352-357.
7. Fina L, Molgaard H, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417-2420.
8. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol. 1991;96:25-31.
9. Kuzu I, Bicknell R, Harris AL, Jones M, Gatter KC, Mason DY. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumors. J Clin Pathol. 1992;45:143-148.
10. Schaerer L, Schmid MH, Mueller B, Dummer RG, Burg G, Kempf W. Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. Am J Dermatopathol. 2000;22:140-14.
11. Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. Oncol Rep. 2005;14:251-255.
12. Korkolopoulou P, Konstantinidou AE, Kavantzas N, et al. Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch. 2001;438:603-611. (Pubitemid 32662380)
13. Sauter G, Algaba F, Amin MB, et al. Non invasive urothelial tumors. In: Elbe JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and Genetics: Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press;2004:110-111.
14. Martinez-Pineiro JA, Flores N, Isorna S, et al., for CUETO (Club Urologico Espanol de Tratamiento Oncologico). Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacilli Calmette-Guerin with a reduced dose of 27 mg in superficial bladder cancer. BJU Int. 2002;89:671-680. (Pubitemid 34429530)
15. Dickinson AJ, Fox SB, Persad, RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol. 1994;74:762-766. (Pubitemid 24378079)
16. Jaeger TM, Weidner N, Chew K, et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 1995;154:69-71.
17. Sagol O, Yorukoglu K, Sis B, et al. Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder? Urology. 2001;57:895-899. (Pubitemid 32405308)
18. Dinney CP, Babkowski RC, Antelo M, et al. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol. 1998;160:1285-1290. (Pubitemid 29480499)
19. Ozer E, Mungan MU, Tuna B, Kazimoglu H, Yorukoglu K, Kirkali Z. Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer. Urology. 1999;54:50-55. (Pubitemid 29323332)
20. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
21. Jaeger TM, Weidner N, Chew K, et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 1995;154:69-71.
22. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9-19.
23. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401-409. (Pubitemid 24058195)
24. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastases in head-and-neck squamous cell carcinoma. Int J Cancer. 1993;55:739-744. (Pubitemid 23354886)
25. Tenderenda M, Rutkowski P, Jesoniek-Kupnicka D, Kubiak R. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res. 2001;7:129-134. (Pubitemid 32729764)
26. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res. 1996;56:2013-2016. (Pubitemid 26119899)
27. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149-153.
28. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991;6:1677-1683. (Pubitemid 21924273)
29. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science.